ABSI stock icon

Absci
ABSI

$3.98
4.58%
 

About: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Employees: 156

0
Funds holding %
of 6,689 funds
0
Analysts bullish %
of 8 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

767% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 6

248% more call options, than puts

Call options by funds: $2.42M | Put options by funds: $696K

142% more capital invested

Capital invested by funds: $142M [Q4 2023] → $344M (+$202M) [Q1 2024]

114% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 14

69% more funds holding

Funds holding: 67 [Q4 2023] → 113 (+46) [Q1 2024]

17.33% more ownership

Funds ownership: 36.3% [Q4 2023] → 53.63% (+17.33%) [Q1 2024]

Research analyst outlook

8 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$5
26%
upside
Avg. target
$8.13
104%
upside
High target
$13
227%
upside

8 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Swayampakula Ramakanth
76%upside
$7
Buy
Reiterated
15 May 2024
Truist Securities
Robyn Karnauskas
126%upside
$9
Buy
Maintained
26 Mar 2024
HC Wainwright & Co.
Swayampakula Ramakanth
76%upside
$7
Buy
Reiterated
22 Mar 2024
Scotiabank
George Farmer
227%upside
$13
Sector Outperform
Initiated
14 Mar 2024
Truist Securities
Robyn Karnauskas
126%upside
$9
Buy
Reiterated
6 Mar 2024

Financial journalist opinion